Oren Eyal, Banerji Aleena, Clark Sunday, Camargo Carlos A
Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Ann Allergy Asthma Immunol. 2007 Nov;99(5):429-32. doi: 10.1016/S1081-1206(10)60568-6.
Research on the use of more than 1 dose of epinephrine in the treatment of food-induced anaphylaxis is limited.
To perform a medical record review to examine the frequency of repeated epinephrine treatments in patients presenting with food-induced anaphylaxis to the emergency department (ED).
We reviewed 39 medical records of patients who presented with food-induced allergic reactions to the Massachusetts General Hospital ED during a 1-year period. The analysis focused on the timing of the onset of symptoms and on the number of epinephrine treatments given before and during the ED visit.
Of the 39 patients, 34 had an acute food-induced allergic reaction. Nineteen had anaphylaxis. Twelve patients with anaphylaxis (63%; 95% confidence interval, 38%-84%) received at least 1 dose of epinephrine, and 3 (16%; 95% confidence interval, 3%-40%) were given 2 doses. Although statistical analysis was not possible, repeated epinephrine treatment occurred in patients with anaphylaxis to peanut or tree nut and hypotension. There was no apparent association between time from ingestion of the causative agent to epinephrine treatment(s).
Of patients presenting to the ED with food-induced anaphylaxis, approximately 16% were treated with 2 doses of epinephrine. This study supports the recommendation that patients at risk for food-induced anaphylaxis carry 2 doses of epinephrine. Further study is needed to confirm these results and to expand them to patients who do not present to the ED because that group may have a lower frequency of epinephrine use.
关于使用超过一剂肾上腺素治疗食物诱导性过敏反应的研究有限。
进行病历回顾,以检查因食物诱导性过敏反应就诊于急诊科(ED)的患者重复使用肾上腺素治疗的频率。
我们回顾了在一年期间因食物诱导性过敏反应就诊于麻省总医院急诊科的39例患者的病历。分析重点在于症状出现的时间以及急诊就诊前和就诊期间给予肾上腺素治疗的次数。
39例患者中,34例发生急性食物诱导性过敏反应。19例发生过敏反应。12例过敏反应患者(63%;95%置信区间,38%-84%)接受了至少一剂肾上腺素治疗,3例(16%;95%置信区间,3%-40%)接受了两剂治疗。尽管无法进行统计分析,但对花生或坚果过敏且伴有低血压的过敏反应患者出现了重复使用肾上腺素治疗的情况。从摄入致病原到进行肾上腺素治疗的时间之间没有明显关联。
因食物诱导性过敏反应就诊于急诊科的患者中,约16%接受了两剂肾上腺素治疗。本研究支持食物诱导性过敏反应风险患者携带两剂肾上腺素的建议。需要进一步研究以证实这些结果,并将其扩展至未就诊于急诊科的患者,因为该组患者使用肾上腺素的频率可能较低。